Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Colosseum Behandling AB
AB
Active
Org 5591608459
Bangårdsgatan 13, 753 20
Uppsala
Other residential care activities n.e.c.
·
NACE 8799
Est. 2018 · 8 years old
31 employees
Monitor
Share
Sweden
/
Companies
/
Other residential care activities n.e.c.
/
Colosseum Behandling AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
51M
38M
26M
13M
0M
2021: 17M
17M
2021
2022: 16M (-6% vs 2021)
16M
-6%
2022
2023: 17M (+6% vs 2022)
17M
+6%
2023
2024: 26M (+53% vs 2023)
26M
+53%
2024
2025: 41M (+58% vs 2024)
41M
+58%
2025
EBITDA
SEK millions
14M
10M
7M
3M
0M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 3M
3M
2023
2024: 8M (+167% vs 2023)
8M
+167%
2024
2025: 11M (+38% vs 2024)
11M
+38%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
41 050
25 715
16 976
15 574
17 476
Staff expenses
−19 485
−11 621
−8 977
−9 909
—
EBITDA
11 450
7 998
2 827
−431
339
Depreciation & amort.
−334
−197
−145
−136
−49
EBIT
11 115
7 801
2 682
−566
290
Net financials
−56
−35
−44
−53
−76
Profit before tax
9 559
6 266
2 588
−619
214
Tax
−1 998
−1 294
−401
—
−53
Net profit
7 561
4 972
2 187
−619
161
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
19 133
12 723
6 963
3 538
4 887
Equity
8 602
6 541
3 569
1 382
2 001
Long-term debt
896
657
520
728
873
Short-term debt
6 636
4 025
2 875
1 428
2 013
Total debt
7 532
4 682
3 394
2 156
2 886
Financial ratios
5-year trend
EBITDA margin
27,9 %
This company
15,8 %
Market median
This company
Market median
77% above market
2021
2025
Equity ratio
45,0 %
This company
38,2 %
Market median
This company
Market median
18% above market
2021
2025
Return on equity
87,9 %
This company
18,4 %
Market median
This company
Market median
378% above market
2021
2025
Net profit margin
18,4 %
This company
8,1 %
Market median
This company
Market median
127% above market
2021
2025
Asset turnover
2,15×
This company
1,12×
Market median
This company
Market median
92% above market
2021
2025
Debt / equity
1,22×
This company
0,62×
Market median
This company
Market median
97% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
View
PDF
More on Colosseum Behandling AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
